JPOST Repository / Database Japan Japan Proteome Standard Repository/Database

Recent posts

event

jPOST 10th anniversary symposium

2025-07-16 jpost

Symposium details in Japanese

event

JCompMS 10th workshop

2025-07-16 jpost

Workshop details in Japanese

event

JCompMS 4th hackathon

2025-05-15 jpost

Hackathon details in Japanese

event

JCompMS 9th workshop

2024-04-4 jpost

Workshop details in Japanese

other

jPOST repository will be stopped. (on Nov. 24-46)

2023-11-24 jpost

jPOSTrepo will be unavailable during the time shown below due to a scheduled system maintenance. We thank you for your understanding and cooperation in this matter. Date and Time: Friday, November 24, 17:00 – Sunday, November 26, 18:00 (UTC+9)

jPOST
  • About
  • Repository
  • Database
  • Workflow
  • Gadgets
  • COVID-19
  • Help
  • FAQ
  • Contact
  • rss
other

jPOST will publish the re-analyzed proteome data related to COVID-19

2020-07-8 jpost

jPOST will publish the re-analyzed proteome data related to COVID-19 as soon as possible to support the scientific community for overcoming the world-wide crisis.

Current progress: 100% [ Last modified date: 2021-07-13 ]

COVID-19 datasets

Analysis target
PXD019113 The Global Phosphorylation Landscape of SARS-CoV-2 Infection [JPST001767, JPST001768]
PXD019645 Data, reagents, assays and merits of proteomics for SARS-CoV-2 research and testing [JPST001769, JPST001770, JPST001771, JPST001772, JPST001773, JPST001774, JPST001775]
PXD019423 MS analysis of SARS-CoV2 proteins from patient samples. [JPST001776]
PXD018804 Extensive proteomic dataset of Vero E6 cells infected by Italy-INMI1 SARS-CoV-2 virus at Day 4 post-infection. [JPST001777]
PXD018594 Shotgun proteomics of Vero E6 cells infected by Italy-INMI1 SARS-CoV-2 virus. [JPST001778]
PXD018357 Inhibition of growth factor signaling prevents SARS-CoV-2 replication. [JPST001779, JPST001780]
PXD018117 A SARS-CoV-2-Human Protein-Protein Interaction Map Reveals Drug Targets and Potential Drug-Purposing. [JPST001781]
PXD018581 Proteomics of SARS-CoV and SARS-CoV-2 infected cells. [JPST001782, JPST001783]
PXD018241 Characterisation of the transcriptome and proteome of SARS-CoV-2 using direct RNA sequencing and tandem mass spectrometry reveals evidence for a cell passage induced in-frame deletion in the spike glycoprotein that removes the furin-like cleavage site. [JPST001784, JPST001785, JPST001786]
PXD017710 Proteome and Translatome of SARS-CoV-2 infected cells
Currently analysis pending
PXD019221 Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
PXD018970 Urine proteomics profiling of the COVID-19
Not for analysis
PXD018307 The Analysis of Plasma Metabolome and Lipidome of Patients with COVID-19
PXD019300 SARS-CoV-2_PRM_SRM_targeted_acquisitions
PXD019232 Proteomic and Metabolomic Characterization of COVID-19 Patient Sera MRMHR
PXD018760 TARGETED PROTEOMICS FOR THE DETECTION OF SARS-COV-2 PROTEINS
PXD018682 MS analysis of SARS-CoV2 proteins from patient samples
PXD019163 Glycosylation analysis of SARS-CoV-2 S and hCoV-HKU1 S
PXD019119 Fast and low-cost detection of SARS-CoV-2 peptides by tandem mass spectrometry in clinical samples
PXD019282 N-glycosites and O-glycosites on Spike glycoprotein of SARS-CoV-2

© Copyright 2021 jPOST